Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087620
Status:
TERMINATED
Last Update Posted:
2017-02-03
First Post:
2004-07-12
Brief Title:
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
ACTUAL
Primary Completion Date:
2004-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-12
First Submit QC Date:
July 13 2004
Study First Post Date:
2004-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-02
Last Update Post Date:
2017-02-03
Last Update Post Date Type:
ESTIMATED